Personalized medicine Europe: Health, genes and society: Tel-Aviv University, Tel-Aviv, Israel, June 19 -21, 2005

In summary, we believe that pharmacogenetics will not replace, but enhance, existing good medical practice. A deliberate approach starts with investing more in studies aimed at clarifying relations between genotypes and drug response phenotypes (both safety and efficacy), educating healthcare professionals by illustrating the benefits of pharmacogenomics, and by educating society about the potential benefits for healthcare from the new genomics and proteomics technologies. We feel that the Tel-Aviv workshop on personalized medicine has provided a competent venue for this theme.